Drugs Made In America Acquisition II Corp. (DMII)

DMII Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024
Period Ending	Dec 31, 2024
Cash & Equivalents	0.02
Cash & Short-Term Investments	0.02
Prepaid Expenses	0.04
Total Current Assets	0.06
Long-Term Deferred Charges	0.08
Total Assets	0.14
Accrued Expenses	0
Short-Term Debt	0.25
Total Current Liabilities	0.25
Total Liabilities	0.25
Common Stock	0
Additional Paid-In Capital	0.03
Retained Earnings	-0.15
Shareholders' Equity	-0.12
Total Liabilities & Equity	0.14
Total Debt	0.25
Net Cash (Debt)	-0.23
Working Capital	-0.2
Tangible Book Value	-0.12

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q